Kimberly-Clark de Mexico SAB de CV (ADR) (NASDAQ:KCDMY) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: September 16, 2016
Just yesterday Kimberly-Clark de Mexico SAB de CV (ADR) (NASDAQ:KCDMY) traded 1.89% lower at $11.57. The company’s 50-day average is $11.97 and its 200-day moving average is $11.73. The last close is down 7.10% relative to the two hundred day moving average, compared with the S&P 500 which has decreased -0.01% over the date range. Trading volume was was up over the average, with 39,646 shares of KCDMY changing hands over the typical 27,420 shares..
Zacks Investment Research has upgraded Kimberly-Clark de Mexico SAB de CV (ADR)(NASDAQ:KCDMY) to Hold in a report released 9/12/2016.
See Graphic Below:
Kimberly-Clark de Mexico SAB de CV (ADR) has a 52 week low of $10.44 and a 52 week high of $12.95 with a P/E ratio of 27 and has a market capitalization of $0.0.
Brief Synopsis On Kimberly-Clark de Mexico SAB de CV (ADR) (NASDAQ:KCDMY)
Kimberly-Clark de Mexico, S.A.B. de C.V. is engaged in the manufacture and commercialization of disposable products for daily use by consumers within and away from home, such as diapers and child care products, feminine pads, incontinence care products, bath tissue, napkins, facial tissue, hand and kitchen towels, wet wipes and healthcare products. The Company’s brands include Huggies, KleenBebe, Kleenex, Kimlark, Petalo, Cottonelle, Depend, Kotex and Evenflo. The Company’s segments include Consumer Products, Professional and Health Care, and Exports. The Company’s baby and child care products include Diapers, Baby wipes, Shampoo, Body lotions and bar soaps, and Feeding products. The Company’s home products include toilet paper, paper towels, antibacterial gel, food wraps and bar soaps. The Company’s adult care products include underwear, cleansing cloths and protector pads. The Company’s professional products include Jumbo toilet paper, Hand towels, and Industrial rags and dispensers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.